Thomas Fulton Wilson McKillop

Professional at Academy of Medical Sciences

Thomas Fulton Wilson McKillop

Thomas Fulton Wilson McKillop

Professional at Academy of Medical Sciences

Overview
Career Highlights

The Science Council
European Federation Of Pharmaceutical Industries And Associations
Society of Chemical Industry

RelSci Relationships

1150

Number of Boards

16

Birthday

03/19/1943

Age

76

Number of Awards

1

Relationships
RelSci Relationships are individuals Thomas Fulton Wilson McKillop likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Partner at KPMG LLP

Relationship likelihood: Strong

Professor of Pathology at Harvard University - Harvard Medical School

Relationship likelihood: Strong

Vice Chairman at UCB Pharma SA - Belgium

Relationship likelihood: Strong

Former Executive Vice President, Pharmaceutical Operations at Eli Lilly & Company

Relationship likelihood: Strong

Corporate Director & General Counsel at Almirall SA

Relationship likelihood: Strong

Former Executive Director, Development at AstraZeneca Plc

Relationship likelihood: Strong

Former Chief Executive Officer & Executive Director at UCB S. A.

Relationship likelihood: Strong

Chief Executive Officer & Director at Almirall SA

Relationship likelihood: Strong

Honorary Fellow at Academy of Medical Sciences

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at Celltech Group Plc

Relationship likelihood: Strong

Paths to Thomas Fulton Wilson McKillop
Potential Connections via
Relationship Science
You
Thomas Fulton Wilson McKillop
Professional at Academy of Medical Sciences
Education
PhD in Chemistry

Founded in 1451, Glasgow is the fourth-oldest university in the English-speaking world. Over the last five centuries and more, we’ve constantly worked to push the boundaries of what’s possible. We’ve fostered the talents of seven Nobel laureates, one Prime Minister and Scotland’s inaugural First Minister. We’ve welcomed Albert Einstein to give a lecture on the origins of the general theory of relativity. Scotland’s first female medical graduates completed their degrees here in 1894 and the world’s first ultrasound images of a foetus were published by Glasgow Professor Ian Donald in 1958. In 1840 we became the first university in the UK to appoint a Professor of Engineering, and in 1957, the first in Scotland to have an electronic computer. All of this means that if you choose to work or study here, you’ll be walking in the footsteps of some of the world’s most renowned innovators, from scientist Lord Kelvin and economist Adam Smith, to the pioneer of television John Logie Baird.

Memberships
Member
Current

The Royal Society is a self-governing Fellowship of many of the world’s most distinguished scientists drawn from all areas of science, engineering, and medicine. The Society’s fundamental purpose, reflected in its founding Charters of the 1660s, is to recognise, promote, and support excellence in science and to encourage the development and use of science for the benefit of humanity. The Society has played a part in some of the most fundamental, significant, and life-changing discoveries in scientific history and Royal Society scientists continue to make outstanding contributions to science in many research areas. The Royal Society is the national Academy of science in the UK, and its core is its Fellowship and Foreign Membership, supported by a dedicated staff in London and elsewhere. The Fellowship comprises the most eminent scientists of the UK, Ireland and the Commonwealth.

Member
Current

ERT today brings together up to 50 chief executives and chairmen of major multinational companies of European parentage, covering a wide range of industrial sectors. Individuals join at the personal invitation of existing Members, which confers on ERT membership a personal rather than corporate character. ERT Members meet twice a year, in person, at Plenary Sessions. At these Plenary Sessions, Members determine ERT’s work programme, set priorities and establish specialised Working Groups to work on them. Decisions are taken by consensus. The ERT Chairman, two vice-Chairmen, the former ERT Chairman and five other elected Members form the Steering Committee. The Steering Committee reviews ERT activities and makes recommendations to the Plenary Sessions. Each ERT Member nominates an Associate to act as a main point of liaison at working level and to help implement the decisions taken by Members. Much of the work is done by the Working Groups established by the Plenary Sessions. They are chaired by ERT Members and comprise Members, Associates and experts from the companies behind ERT Members. The Working Groups present proposals to the Plenary and take a leading role in the drafting of official ERT messages and positions. The Secretary General is in charge of a small Executive based in Brussels, which coordinates projects, acts as a contact point, provides administrative support and publishes the ERT reports.

Career History
Professional
Current
Chief Executive Officer
Prior

Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK.

President
2007 - 2011
Boards & Committees
Non-Executive Director
2004 - 2009

BP Plc operates as an integrated oil and gas company. It operates through three segments: Upstream, Downstream and Rosneft. The Upstream segment engages in the oil and natural gas exploration, field development, and production; midstream transportation, and storage and processing; and marketing and trade of natural gas, including liquefied natural gas, and power and natural gas liquids. It also owns and manages crude oil and natural gas pipelines; processing facilities and export terminals; and LNG processing facilities and transportation, as well as NGL extraction business. The Downstream segment refines, manufactures, markets, transports, supplies, and trades in crude oil, petroleum, and petrochemicals products and related services to wholesale and retail customers. It offers lubricants and related products under the Castrol, BP, and Aral brands to the automotive, industrial, marine, and energy markets; and petrochemicals products, such as purified terephthalic acid, paraxylene, acetic acid, olefins and derivatives, and specialty petrochemicals products. The Rosneft segment engages in the exploration and production of hydrocarbons in the United States, Canada, Vietnam, Venezuela, Brazil, Algeria, the United Arab Emirates, Turkmenistan, and Norway; and offers jet fuel, bunkering, bitumen, and lubricants. The firm also produces bioethanol, sugar, and biobutanol; exports power to the local grid; transports hydrocarbon products through shipping and chartering services. The company was founded by William Knox D'Arcy in 1908 and is headquartered in London, the United Kingdom.

Deputy Chairman
1975 - Prior

ICI Pharmaceuticals is a Health Care company.

Non-Executive Director
Prior
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100 - $499
2012

RECEIVE, HOLD, INVEST AND ADMINISTER PROPERTY AND TO MAKE EXPENDITURES TO OR FOR THE BENEFIT OF CALIFORNIA STATE UNIVERSITY, FRESNO.

Awards & Honors
2004
University of St. Andrews
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thomas Fulton Wilson McKillop. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thomas Fulton Wilson McKillop's profile does not indicate a business or promotional relationship of any kind between RelSci and Thomas Fulton Wilson McKillop.